PRAX
NASDAQ
$304.43
Praxis Precision Medicines Inc (PRAX)
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $610.05 (+100.39%)
Market Cap
$8.87B
FCF 5Y CAGR
+32.25%
Free Cash Flow Yield
-3.18%
Beta (5Y)
0.93
Price Chart
Valuation
Market Cap$8.87B
P/S953.14
P/B6.48
Profitability
Gross Profit (TTM)-$284M
EBITDA-$357M
EPS-$13.72
Financial Health
Free Cash Flow Yield-3.18%
Growth & Risk
EPS 5Y CAGR-18.18%
FCF 5Y CAGR+32.25%
Beta (5Y)0.93
Sharpe Ratio1.39